Association of Regulatory Compliance Behaviour with HR Compliance Training and Quality Assurance Enforcement in the Saudi Pharmaceutical Sector: Testing Vision 2030-Driven Healthcare Innovation Capability as a Moderator
DOI:
https://doi.org/10.65080/ajbmss.v2i2.CMT2622101006Keywords:
HR compliance training, quality assurance enforcement, regulatory compliance behaviour, pharmaceutical industry, vision 2030-driven healthcare innovation capability, Saudi ArabiaAbstract
Introduction: This study explored the association between HR compliance training and quality assurance enforcement with regulatory compliance behaviour among the Saudi pharmaceutical industry and how Vision 2030-driven healthcare innovation capabilities moderate this association.
Methodology: Data were gathered using a structured questionnaire completed by 400 HR compliance officers and quality assurance managers. Partial least squares structural equation modelling (PLS-SEM) was used to test the hypothesised relationships. The findings indicate that regulatory compliance behaviour is associated with HR compliance training (β = 0.380, p = 0.001), but quality assurance enforcement does not show a significant association with regulatory compliance behaviour (β = 0.074, p= 0.313). Vision 2030-driven healthcare innovation capability had a marginally significant moderating impact only on the association between HR compliance training and compliance behaviour (β = 0.121, p = 0.050), but not on quality assurance enforcement and HR compliance training (β = 0.004, p = 0.942).
Results: The results showed that capability-building mechanisms might be a relatively more effective predictor of compliance behaviour than structural enforcement mechanisms, but the effect sizes were relatively small.
Conclusion: The findings of this research have practical implications for informing the design of training and maximising compliance outcomes by capitalising on digital innovation.
Downloads
References
Aburumman, O. J., Omar, K., Al Shbail, M., & Aldoghan, M. (2022). How to deal with the results of PLS-SEM?. In International Conference on Business and Technology (pp. 1196-1206). Cham: Springer International Publishing.
https://doi.org/10.1007/978-3-031-08954-1_101
Adola, T. B., Assefa, D., Ejeta, F., Gashe, F., Paulos, G., & Borga, D. K. (2026). Assessment of current good manufacturing practice (cGMP) compliance in pharmaceutical manufacturers in Ethiopia: Cross-sectional descriptive study. PloS One, 21(3), e0343881. https://doi.org/10.1371/journal.pone.0343881
Altamuro, J. L. M., Gray, J. V., & Zhang, H. (2022). Corporate integrity culture and compliance: A study of the pharmaceutical industry. Contemporary Accounting Research, 39(1), 428-458.
https://doi.org/10.1111/1911-3846.12727
Anbil, P., Deshpande, P. & Khot, P. (2026). Quality and Compliance in the Pharmaceutical Industry: Navigating a Transformed Landscape. Pharmaceutical Commerce. 21(1). Available from: https://www.pharmaceuticalcommerce.com/view/quality-and-compliance-in-the-pharmaceutical-industry (Accessed on: 03-08-2026).
Arab, O. O., Aldayan, M., Almowaizri, K., Alghamdi, A., Alghamdi, J., & Alharf, A. (2025). Descriptive Analysis of Good Clinical Practice Inspection Findings from the Saudi Food and Drug Authority. Therapeutic Innovation & Regulatory Science, 59, 295–303. https://doi.org/10.1007/s43441-024-00731-5
Bao, Y., Buhay, N. & Zheng, Q. (2024). A Dynamic Model for GMP Compliance and Regulatory Science. Journal of Pharmaceutical Innovation, 19. 25. https://doi.org/10.1007/s12247-024-09825-x
Barney, J. B. (2001). Resource-based theories of competitive advantage: A ten-year retrospective on the resource-based view. Journal of Management, 27(6), 643-650. https://doi.org/10.1177/014920630102700602
Bernasconi, M., Friedli, T., & von Dzengelevski, O. (2025). The impact of current good manufacturing practices inspections on continuous improvement mindset in the pharmaceutical industry. Journal of Pharmaceutical Innovation, 20, 282. https://doi.org/10.1007/s12247-025-10200-7
Campbell, S., Greenwood, M., Prior, S., Shearer, T., Walkem, K., Young, S., ... & Walker, K. (2020). Purposive sampling: complex or simple? Research case examples. Journal of Research in Nursing, 25(8), 652-661.
https://doi.org/10.1177/1744987120927206
Chen, H., Qin, L., Jiang, C., Qin, M., Sun, Y., & Luo, J. (2023). Characteristics, risk management and GMP standards of pharmaceutical companies in China. Frontiers in Public Health, 11, 1103555.
https://doi.org/10.3389/fpubh.2023.1103555
Colman, H. (2026). HR Compliance Training: A Practical Guide for 2026. iSpring LMS. Available from: https://www.ispring.com/knowledge-hub/hr-compliance-training (Accessed on: 03-08-2026).
Conrad, J., Silver, P., & Elsner, N. (2019). Maintaining value in pharmaceutical compliance. Deloitte Insights. Available from: https://www.deloitte.com/us/en/insights/industry/life-sciences/pharmaceutical-compliance-technology.html (Accessed on: 03-08-2026).
Cuffari, B. (2025). Market Report 2025: Pharmaceutical Manufacturing. News-Medical Life Sciences. Available from: https://www.news-medical.net/life-sciences/Market-Report-2025-Pharmaceutical-Manufacturing.aspx
Fellows, M., Friedli, T., Li, Y., Maguire, J., Rakala, N., Ritz, M., Bernasconi, M., Seiss, M., Stiber, N., Swatek, M., & Viehmann, A. (2022). Benchmarking the quality practices of global pharmaceutical manufacturing to advance supply chain resilience. The AAPS Journal, 24(6), 111. https://doi.org/10.1208/s12248-022-00761-7
Ghanad, A. (2023). An overview of quantitative research methods. International Journal of Multidisciplinary Research and Analysis, 6(08), 3794-3803. https://doi.org/10.47191/ijmra/v6-i8-52
Gillani, A. H., Arshad, H., Yang, C., Arshed, M., Atif, N., Bashir, K., Abbas Malik, H. M., & Fang, Y. (2025). Assessing the effects of online educational intervention on pharmaceutical promotions: a pre-post study among medical and pharmacy students in Pakistan. Frontiers in Pharmacology, 16, 1616631. https://doi.org/10.3389/fphar.2025.1616631
Global Health Exhibition (2024). How Saudi’s Vision 2030 is going to Transform the Healthcare Industry. Available from: https://www.globalhealthsaudi.com/en/news/healthcare-insights/how_saudis_vision_2030_is_going_to_transform_the_healthcare.html (Accessed on: 03-08-2026).
Hair, J., & Alamer, A. (2022). Partial Least Squares Structural Equation Modeling (PLS-SEM) in second language and education research: Guidelines using an applied example. Research Methods in Applied Linguistics, 1(3), 100027.
https://doi.org/10.1016/j.rmal.2022.100027
Jacobs, A. (2023). Why compliance training fails. SSRN. https://dx.doi.org/10.2139/ssrn.5268898
Jessica, R. (2025). Navigating the complex world of pharma regulatory compliance: Finding the sweet spot between safety & innovation. Available from: https://gmppros.com/pharma-regulatory-compliance/ (Accessed on: 03-08-2026).
Julian, C., & Abbas, A. (2020). Regulatory Compliance in HR: A Strategic Workforce Planning Approach. ResearchGate.
https://doi.org/10.13140/RG.2.2.19928.76806
Khaliq, S. A., Kashif, M., Shaik, M. J., & Hussain, I. (2025). A narrative review on automation and digitalization in quality control laboratories of pharmaceuticals. International Journal of Pharmacy & Integrated Health Sciences, 6(2), 89-98.
https://doi.org/10.56536/ijpihs.v6i2.262
Klein, T. A., Seelbach, C. L., & Brannan, G. D. (2023). Quality Assurance. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557503/ (Accessed on: 03-08-2026).
Kuiper, M. E. (2025). There is no quick fix: Compliance officers’ views on organisational behavioural change. Journal of Business Ethics, 206, 461-486. https://doi.org/10.1007/s10551-025-06183-7
Manor, K. (2025). Is a compliance training program effective? A comparison analysis of compliance officers' perceptions and recommended practices in multinational corporations regarding compliance etraining program effectiveness. Journal of Legal, Ethical & Regulatory Isses, 28 (2). https://doi.org/10.13140/RG.2.2.35961.38245
Muhammad, F., Iqbal, N., Asim, M., & Ali, M. A. (2025). Impact of training program components on perceived training utility and cGMP compliance behaviour: An evidence from pharmaceutical industry (Pakistan). Journal of Asian Development Studies, 14(4), 209-224. https://doi.org/10.62345/jads.2025.14.04.1661
Rahman, M. M. (2023). Sample size determination for survey research and non-probability sampling techniques: A review and set of recommendations. Journal of Entrepreneurship, Business and Economics, 11(1), 42-62. Available from: https://scientificia.com/index.php/JEBE/article/view/201/190 (Accessed on: 03-08-2026).
Rasoolimanesh, S. M. (2022). Discriminant validity assessment in PLS-SEM: A comprehensive composite-based approach. Data Analysis Perspectives Journal, 3(2), 1-8. https://www.researchgate.net/profile/S-Mostafa-Rasoolimanesh/publication/356961783_Discriminant_validity_assessment_in_PLS-SEM_A_comprehensive_composite-based_approach/links/61b465e31d88475981dfde95/Discriminant-validity-assessment-in-PLS-SEM-A-comprehensive-composite-based-approach.pdf (Accessed on: 03-08-2026).
Saudi Food and Drug Authority (2026). SFDA conducts field visits to 197 pharmaceutical, medical device factories in 2023. Available from: https://www.sfda.gov.sa/en/news/878322 (Accessed on: 03-08-2026).
Saudi Gazette (2024). SFDA slaps fines of SR678400 on 24 pharmaceutical firms for violations. Available from: https://saudigazette.com.sa/article/645811/SAUDI-ARABIA/SFDA-slaps-fines-of-SR678400-on-24-pharmaceutical-firms-for-violations (Accessed on: 03-08-2026).
Science & Innovation Network (2022). UK Science & Innovation Network Country Snapshot Kingdom of Saudi Arabia. Available from: https://assets.publishing.service.gov.uk/media/6391ae8fd3bf7f1bd42de7be/KSA_Snapshot-2022.pdf (Accessed on: 03-08-2026).
SFDA (2025). SFDA GMP inspection deficiency data trend 2025. Available from: https://www.sfda.gov.sa/sites/default/files/2026-03/DF2025.pdf (Accessed on: 03-08-2026).
Teece, D. J. (2022). The evolution of the dynamic capabilities framework. In Artificiality and Sustainability in Entrepreneurship: Exploring the unforeseen, and paving the way to a sustainable future. FGF Studies in Small Business and Entrepreneurship. (pp. 113-129). Cham: Springer International Publishing.
https://doi.org/10.1007/978-3-031-11371-0_6
Ullagaddi, P. (2024). Leveraging digital transformation for enhanced risk mitigation and compliance in pharma manufacturing. Journal of Advances in Medical and Pharmaceutical Sciences, 26(6), 75-86.
https://doi.org/10.9734/jamps/2024/v26i6697
Waheed, A., Waheed, S., Hussain, S., & Majeed, A. (2024). The HR revolution: Redefining performance paradigms in Pakistan's pharma landscape through moderating role of innovative climate. PloS One, 19(5), e0301777.
https://doi.org/10.1371/journal.pone.0301777
WHO (2023). Saudi Arabia regulatory system becomes third to reach WHO Maturity Level 4. Available from: https://www.who.int/news/item/30-10-2023-saudi-arabia-regulatory-system-becomes-third-to-reach-who-maturity-level-4 (Accessed on: 03-08-2026).
Zubair, M. (2024). Navigating the complex landscape of regulatory compliance in the pharmaceutical industry. Trends in Telemedicine & E-health, 5(2). http://dx.doi.org/10.31031/TTEH.2024.05.000607
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Saleem Raza Bhatti (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
